We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Ranitidine – MHRA drug alert issued as Creo Pharma Limited and Tillomed Laboratories recall unexpired stock
Reclassification of Dovonex Psoriasis Ointment approved by MHRA
The CMA has published the full non-confidential decision following its investigation into unfair pricing for phenytoin sodium capsules in the UK.
The UK Government has announced its intent to pursue an innovative new collaboration to tackle heart disease with pharmaceutical company Novartis
First published during the 2019 to 2022 Johnson Conservative government
The CMA has provisionally found that Actavis UK has broken competition law by charging excessive prices to the NHS for hydrocortisone tablets.
A crackdown on fake medicines and medical devices by the Medicines and Healthcare products Regulatory Agency (MHRA) has netted a haul of more than 1 million doses worth in excess of £2 million.
Previously co-dydramol (dihydrocodeine/paracetamol) was available only in the ratio 1:50 (co-dydramol 10/500 mg). Two products are now available with a higher strength of dihydrocodeine (co-dydramol 20/500 mg and 30/500 mg tablets). It is therefore important that co-dydramol products are prescribed...
Letter from the Advisory Council on the Misuse of Drugs to parliamentary under secretary of state James Brokenshire.
Enforcement officers from the Medicines and Healthcare products Regulatory Agency (MHRA) have seized 23,000 doses of potentially dangerous slimming pills, with an estimated value of £30,000, during a raid on an address in Waterlooville, Hampshire.
DNP was deemed unfit for human consumption in 1938 following reports of severe adverse health effects.
Upper Tribunal Administrative Appeals Chamber decision by Judge Church on 5 March 2020.
Upper Tribunal Administrative Appeals Chamber decision by Judge Gamble on 9 February 2016.
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
New violence toolkit for businesses alerts companies to the hidden issue of domestic violence at work.
New online system, Report Illicit Drug Reaction, launched today to improve knowledge of the harmful effects of new psychoactive substances.
These new measures will give prison officers the tools they need to manage violent and serious incidents that undermine the safety and security of our prisons.
First published during the 2016 to 2019 May Conservative government
Employment Tribunal decision.
Upper Tribunal Administrative Appeals Chamber decision by Judge Ovey on 12 February 2016.
Upper Tribunal Administrative Appeals Chamber decision by Judge Ovey on 19 May 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).